ProShare Advisors LLC Increases Position in NeoGenomics, Inc. (NASDAQ:NEO)
ProShare Advisors LLC increased its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 44.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,445 shares of the medical research company’s stock after purchasing an additional 11,831 shares during the quarter. […]
ProShare Advisors LLC increased its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 44.5% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 38,445 shares of the medical research company’s stock after purchasing an additional 11,831 shares during the quarter. […]
